echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > New model may improve treatment of patients with rheumatoid arthritis and heart disease

    New model may improve treatment of patients with rheumatoid arthritis and heart disease

    • Last Update: 2021-10-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Researchers from Queen Mary University of London have developed a new method for treating heart disease in patients with rheumatoid arthritis (RA)


    Currently, patients with rheumatoid arthritis are particularly susceptible to a heart defect called diastolic dysfunction, which can lead to heart failure, leading to a higher mortality rate in this patient population


    The new study, published in the Proceedings of the National Academy of Sciences (PNAS), addresses this unmet clinical need by developing an experimental model of cardiomyopathy in inflammatory arthritis


    After several attempts, the research team at the William Harvey Institute (WHRI) at Queen Mary’s College successfully identified the correct model by describing experimental animals suffering from arthritis


    The lead author of the study, Professor Mauro Perretti, Professor of Immunopharmacology at Queen Mary University of London, said: "Usually, the description of effective models of the disease can open up new prospects for pathogenic mechanisms and new treatments


    Original search:

    DOI

    10.


    Annexin A1 attenuates cardiac diastolic dysfunction in mice with inflammatory arthritis


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.